HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,921-1,932 of 7,264
Drug study icon
CompletedNCT00916552

Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolarity

Official study title

The Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Patients With Treatment Resistant Depression and in Patients With Remitted Bipolar Disorder - a Proof of Concept Study

This study has finished and is no longer accepting participants.

In Copenhagen
Depression, BipolarityMedication studyAges 18–65
Countries
Denmark
Sponsor
Lars Vedel Kessing, professor, MD, DMSc.
Other study type icon
Active Not RecruitingNCT05966532

Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression

Official study title

Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression (ENSURE; R21 MH130870)

This study is no longer accepting new participants.

Multiple locations, including Arlington
DepressionObservational studyAges 21–80
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Drug study icon
TerminatedNCT00449007

Fluoxetine and Bupropion to Treat people with Depression and Alcoholism

Official study title

A Randomized Controlled Study Comparing Fluoxetine With Bupropion for Impulsivity and Suicidality in Patients With Major Depressive Disorder and Comorbid Alcoholism (Abuse or Dependence)

This study ended early.

In New York
Depression, SuicidalityMedication studyAges 18–65
Countries
United States
Sponsor
New York State Psychiatric Institute
Behavioral study icon
CompletedNCT07014683

Integral Cognitive Remediation for Depression

Official study title

INtegral Cognitive REMediation for Depression (INCREM). Multicentric Randomized Clinical Trial to Investigate Feasibility and Efficacy (Phase II)

This study has finished and is no longer accepting participants.

In Barcelona
DepressionBehavioural studyAges 18–60
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Device study icon
CompletedNCT04485455

iTBS for Adolescent Depression: An Open Label Study Evaluating Safety and Efficacy of Treatment

Official study title

Open Label Study of the Efficacy, Durability, Safety and Feasibility of Intermittent Theta Burst Stimulation (iTBS) in Adolescents With Major Depressive Disorder: Effect Duration, Suicidality, and Non-Suicidal Self Injurious Behavior

This study has finished and is no longer accepting participants.

In Chapel Hill
DepressionDevice studyAges 13–17
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Drug study icon
CompletedNCT04177706

Ketamine for Addiction and Depression

Official study title

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Ketamine for the Treatment of Concurrent Opioid Use Disorder and Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Charleston
Depression, AddictionMedication studyAges 18–65
Countries
United States
Sponsor
Medical University of South Carolina
Drug study icon
CompletedNCT07521358

Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression

Official study title

Effects of Magnesium Supplementation on Serum Brain-Derived Neurotrophic Factor Levels and Cognitive Function in Patients With Depression Receiving Fluoxetine Therapy

This study has finished and is no longer accepting participants.

In Makassar
DepressionMedication studyAges 18–60
Countries
Indonesia
Sponsor
Hasanuddin University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.